Michelini, Giorgia http://orcid.org/0000-0002-0887-7582
Jurgiel, Joseph
Bakolis, Ioannis
Cheung, Celeste H. M.
Asherson, Philip
Loo, Sandra K.
Kuntsi, Jonna
Mohammad-Rezazadeh, Iman
Funding for this research was provided by:
RCUK | Medical Research Council
European Molecular Biology Organization
DH | National Institute for Health Research
Action Medical Research
Article History
Received: 27 April 2018
Revised: 10 January 2019
Accepted: 23 March 2019
First Online: 12 April 2019
Compliance with ethical standards
:
: P.A. has received funding for research by Vifor Pharma and has given sponsored talks and been an advisor for Shire, Janssen-Cilag, Eli-Lilly, Flynn Pharma, and Pfizer regarding the diagnosis and treatment of ADHD. All funds are received by King’s College London and used for studies of ADHD. The other authors declare that they have no conflict of interest.
: All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (London-Surrey Borders Research Ethics Committee) and with the Helsinki Declaration of 1975 (as revised in 1983).